Orbimed Advisors LLC Immatics N.V. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Immatics N.V. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,087,462 shares of IMTX stock, worth $14.8 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
3,087,462
Previous 2,006,381
53.88%
Holding current value
$14.8 Million
Previous $22.9 Million
4.11%
% of portfolio
0.59%
Previous 0.54%
Shares
7 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
92.5MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$50.9 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA10.4MShares$50 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$45 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$34.9 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$31.4 Million0.76% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $366M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...